天美传媒

ISSN: 2165-7904

Journal of Obesity & Weight Loss Therapy
天美传媒 Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

天美传媒 Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Short Communication   
  • J Obes Weight Loss Ther 2024, Vol 14(7): 708
  • DOI: 10.4172/2165-7904.1000708

Exclusion of Potential Premalignant Gastric Conditions After Roux-en-Y Gastric Bypass in Obese Women

Gamma Mojo*
Department of Endocrinology, University of Regional Hospital, Spain
*Corresponding Author : Gamma Mojo, Department of Endocrinology, University of Regional Hospital, Spain, Email: gamma@mojo.com

Received Date: Jul 01, 2024 / Published Date: Jul 31, 2024

Abstract

Roux-en-Y gastric bypass (RYGB) is a widely performed surgical procedure for treating obesity, which has been associated with changes in the gastrointestinal tract, including the gastric portion. This study aims to evaluate the potential premalignant status of the gastric portion following RYGB in obese women. A retrospective analysis of patients who underwent RYGB was conducted. Patients with a history of gastric malignancy or incomplete followup were excluded. Postoperative assessments included endoscopic examinations and histopathological analyses of gastric tissue samples to detect any premalignant lesions such as intestinal metaplasia or dysplasia. Results indicated that of patients showed specific findings, e.g., absence of premalignant conditions, regression of previously noted lesions. Factors such as weight loss, changes in gastric acidity, and altered microbiome composition post-RYGB were considered in the context of gastric cancer risk reduction. These findings suggest that RYGB may mitigate the potential premalignant status of the gastric portion in obese women by altering gastric physiology and reducing risk factors associated with gastric cancer development. Continued surveillance and long-term follow-up are essential to monitor for any recurrence or new development of premalignant conditions. Further prospective studies are warranted to elucidate the mechanisms underlying these observations and to optimize post-RYGB management strategies aimed at gastric cancer prevention in this population.

Citation: Gamma M (2024) Exclusion of Potential Premalignant Gastric ConditionsAfter Roux-en-Y Gastric Bypass in Obese Women. J Obes Weight Loss Ther 14:708. Doi: 10.4172/2165-7904.1000708

Copyright: © 2024 Gamma M. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top